🇺🇸 FDA
Patent

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

granted A61KA61K38/00

Quick answer

US patent 7402659 (Thymic stromal lymphopoietin receptor molecules and uses thereof) held by THE GOVERNMENT OF THE UNITED STATES OF AMERICA expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE GOVERNMENT OF THE UNITED STATES OF AMERICA
Grant date
Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00